10-K/A

FORM 10-K/A

Company: NIKA PHARMACEUTICALS, INC
Filed: March 25, 2021
Period of Report: December 31, 2020
Accession Number: 0001826466-21-000076

View Document ↗ View on SEC.gov ↗